NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin
Publication
, Conference
Wallentin, LC; Christersson, C; Siegbahn, A; Schollin, M; Alexander, JH; Hanna, M; Hylek, EM; Horowitz, J; McMurray, JJV; Granger, CB
Published in: EUROPEAN HEART JOURNAL
August 1, 2012
Duke Scholars
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
August 1, 2012
Volume
33
Start / End Page
51 / 51
Location
Munchen, GERMANY
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Wallentin, L. C., Christersson, C., Siegbahn, A., Schollin, M., Alexander, J. H., Hanna, M., … Granger, C. B. (2012). NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin. In EUROPEAN HEART JOURNAL (Vol. 33, pp. 51–51). Munchen, GERMANY: OXFORD UNIV PRESS.
Wallentin, L. C., C. Christersson, A. Siegbahn, M. Schollin, J. H. Alexander, M. Hanna, E. M. Hylek, J. Horowitz, J. J. V. McMurray, and C. B. Granger. “NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin.” In EUROPEAN HEART JOURNAL, 33:51–51. OXFORD UNIV PRESS, 2012.
Wallentin LC, Christersson C, Siegbahn A, Schollin M, Alexander JH, Hanna M, et al. NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2012. p. 51–51.
Wallentin, L. C., et al. “NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin.” EUROPEAN HEART JOURNAL, vol. 33, OXFORD UNIV PRESS, 2012, pp. 51–51.
Wallentin LC, Christersson C, Siegbahn A, Schollin M, Alexander JH, Hanna M, Hylek EM, Horowitz J, McMurray JJV, Granger CB. NT-proBNP for risk stratification in atrial fibrillation during treatment with apixaban or warfarin. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2012. p. 51–51.
Published In
EUROPEAN HEART JOURNAL
ISSN
0195-668X
Publication Date
August 1, 2012
Volume
33
Start / End Page
51 / 51
Location
Munchen, GERMANY
Publisher
OXFORD UNIV PRESS
Conference Name
Congress of the European-Society-of-Cardiology (ESC)
Related Subject Headings
- Cardiovascular System & Hematology
- 3202 Clinical sciences
- 3201 Cardiovascular medicine and haematology
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology